Together, we reach far beyond the skin
A truly global platform dedicated to medical dermatology
Building on a century of experience with breakthrough medicines, the broadest global portfolio in medical dermatology, and a proven innovation model — we are powering progress.
Featured news
Media
LEO Pharma delivers 10% revenue growth at CER and strengthens late-stage pipeline
LEO Pharma delivers 10% revenue growth at CER and strengthens late-stage pipeline Ballerup, Denmark, 18 August, 2026 – In H1 2026, LEO Pharma delivered strong revenue growth, driven…
Media
LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab in children with moderate-to-severe atopic dermatitis
LEO Pharma announces key results of Phase 2 TRAPEDS-1 trial evaluating pharmacokinetics and safety of tralokinumab in children with moderate-to-severe atopic dermatitis TRAPEDS-1 is a Phase 2 trial…
Media
LEO Pharma’s net-zero and emissions reduction targets validated by SBTi
LEO Pharma’s net-zero and emissions reduction targets validated by SBTi LEO Pharma has achieved Science Based Targets initiative (SBTi) validation for its net-zero climate targets, including its ambition…
At a glance
LEO Pharma is a global leader in medical dermatology. We deliver innovative treatments for skin diseases, building on a century of experience with breakthrough medicines in healthcare.
Group revenue growth (CER)
DKK million/% in 2025
10%
Adjusted EBITDA margin
DKK million/% in 2025
16%
Patients served annually
In 2025
+100m